Press Release | NeoGenomics Laboratories

March 2, 2020

NeoGenomics Announces Three-Year Contract to be Cornerstone Oncology and Cancer Testing Laboratory for Large, National Group Purchasing Organization

February 28, 2020

NeoGenomics To Present At 41st Annual Raymond James Institutional Investor Conference

February 27, 2020

NeoGenomics Reports 40% Revenue Growth to $107 Million in the Fourth Quarter

February 6, 2020

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2019 Earnings Release for February 27, 2020

February 5, 2020

NeoGenomics Announces Leadership Appointments

January 10, 2020

NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million

December 6, 2019

EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas

November 6, 2019

NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients